Skip to main content

Table 2 HCV seroprevalence in subgroups

From: Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis

Categories

Number of studies

Total population

Pooled seroprevalence

95% CI

I2 index (%)

Cochran Q test p-value

Study subjects

General population

10

18,433

3.11

2.05–4.38

92.14

 < 0.001

Blood donors

11

146,509

4.51

3.73–5.35

96.51

 < 0.001

Pregnant women

8

2899

3.95

2.67–5.46

71.86

 < 0.001

Children

2

310

2.11

0.68–4.16

0

0.59

Healthcare workers

2

442

1.57

0.28–3.68

44.09

0.18

MSM

2

485

5.19

0.00–18.25

94.81

 < 0.001

Sex workers

1

325

9.85

6.82–13.34

NA

NA

HIV patients

1

232

7.76

4.63–11.59

NA

NA

Study setting*

Urban

25

156,420

4.02

3.40–4.68

95.44

 < 0.001

Rural

7

12,046

3.27

2.35–4.33

59.24

0.02

Decade of data collection*

1990–2000

2

965

5.33

1.42–11.45

91.06

 < 0.001

2000–2010

13

39,201

3.95

2.85–5.21

90.37

 < 0.001

2010–2020

12

126,111

3.77

3.25–4.32

92.71

 < 0.001

  1. *Analyses performed considering only low-risk populations (general population, blood donors, pregnant women, children)